AsclepiX Therapeutics Funding: $5M Raised, Series A (2018)
AsclepiX Therapeutics is based in Jersey City, NJ. It has raised $5M in total funding. Latest round: Series A.
AsclepiX Therapeutics funding overview
AsclepiX Therapeutics is based in Jersey City, NJ. AsclepiX Therapeutics has raised $5M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series A announced in November 2018. The round record for AsclepiX Therapeutics runs through 2018; nothing later has been disclosed. Investors on record include Barer & Son Capital, Rapha Capital Management, Salem Partners, TEDCO, Piedmont Capital Partners. 5 distinct backers are named across the disclosed rounds.
AsclepiX Therapeutics at a glance
Total raised
$5M
Latest round
Series A
Latest round date
November 2018
Headquarters
Jersey City, NJ
Notable investors
Barer & Son Capital, Rapha Capital Management, Salem Partners, TEDCO, Piedmont Capital Partners
Frequently asked about AsclepiX Therapeutics funding
How much has AsclepiX Therapeutics raised?
AsclepiX Therapeutics has raised $5M in total disclosed funding across the rounds on record.
Who has invested in AsclepiX Therapeutics?
Barer & Son Capital, Rapha Capital Management, Salem Partners, TEDCO, Piedmont Capital Partners are named among the investors backing AsclepiX Therapeutics.
What was the latest AsclepiX Therapeutics funding round?
The most recent disclosed round is a Series A, announced in November 2018.
Where is AsclepiX Therapeutics based?
AsclepiX Therapeutics is based in Jersey City, NJ.
When did AsclepiX Therapeutics last raise?
The last disclosed AsclepiX Therapeutics round closed in November 2018 at Series A.
Totals shown for AsclepiX Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in Jersey City and the investors behind them below.
